CDKN2B and astrocytoma (excluding glioblastoma): Moreover, homozygous deletion of the CDKN2A/CDKN2B tumor suppressor gene locus has been introduced as a molecular biomarker for CNS WHO grade 4 in an IDH-mutant astrocytoma [30, 41].